USE OF PINP AND B-CROSSLAPS IN MONITORING THE TREATMENT OF ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN

Authors

  • Kim O.V. Assistant of the Department of Biological Chemistry of Samarkand State Medical University Author
  • Prof. Yusupov Sh. A. Dr. of Medical Sciences, Scientific Adviser Author

Keywords:

biomarkers, bone metabolism, collagen, acute hematogenous osteomyelitis, telopeptides.

Abstract

Today, acute hematogenous osteomyelitis (AHO) remains a serious problem in childhood. According to the WHO, the annual incidence of AHO among children varies from 2 to 13 cases per 100,000 population, depending on the region, age, and level of medical care. Bone collagen biomarkers represent a new and promising tool in the diagnosis and monitoring of bone pathologies in children.
The aim of the study was to determine the levels of bone type I collagen synthesis and degradation biomarkers (PINP and β-CrossLabs) in children with acute hematogenous osteomyelitis.

Downloads

Published

2025-08-11

Issue

SCMS-11th August, 2025

Section

Articles

How to Cite

USE OF PINP AND B-CROSSLAPS IN MONITORING THE TREATMENT OF ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN. (2025). Scientific Conference on Multidisciplinary Studies, 45-48. https://econfseries.com/index.php/3/article/view/2648